- 질문내용 -
Until August vicerex 350 mg Giving regulators access to data from an existing trial,known as Elixa, to study the treatment창?혲s cardiovascular effectscould affect the integrity of the test, the Paris-based companysaid in a statement today. The drugmaker will resubmit theapplication in 2015, after completion of the study, Sanofi said.The withdrawal isn창?혲t related to safety issues or deficiencies inthe application, Sanofi said.
|
|
